Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET/MRI in Resectable Cervical Carcinoma
NCT04219904Phase 1Active, not recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 2018
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Accuracy of diagnosing depth of invasion on positron emission tomography/magnetic resonance imaging (PET/MRI) at 3 years. Started Sep 2018; status: active, not recruiting.
Beyond the preview
Go deeper on NCT04219904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04219904.